Piramal Pharma Sees Surge in Open Interest Amid Ongoing Stock Decline
Piramal Pharma Ltd has seen a significant rise in open interest, reaching 10,401 contracts, alongside a trading volume of 10,698 contracts, indicating active market participation. However, the stock has underperformed, experiencing consecutive losses and trading below key moving averages, highlighting ongoing market challenges.
Piramal Pharma Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable increase in open interest (OI) today. The latest OI stands at 10,401 contracts, reflecting a rise of 1,021 contracts or 10.88% from the previous OI of 9,380. This uptick in OI comes alongside a trading volume of 10,698 contracts, indicating active participation in the derivatives market.Despite this increase in OI, Piramal Pharma's stock has underperformed relative to its sector, showing a decline of 1.29% today. Over the past two days, the stock has faced consecutive losses, with a total drop of 4.09%. The stock reached an intraday low of Rs 185.12, marking a decrease of 4.35% from its previous close.
In terms of liquidity, the stock remains accessible for trading, with a delivery volume of 23.27 lakh shares on August 5, which has decreased by 2.33% compared to the five-day average. Currently, Piramal Pharma is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a challenging market position.
In summary, while the increase in open interest suggests heightened activity in the derivatives market, the stock's recent performance reflects broader challenges within the market context.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
